Epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity treated with topical application of a novel Staphylococcus epidermidis compound. This is an ASCO Meeting Abstract from the ...
(a–c) The 3D visualization of molecular docking modes of HXTL’s top four active components (luteolin, beta-sitosterol, stigmasterol, quercetin) and top three HXTL-PMOP targets (IL6, AKT1, PI3K). (d) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results